Astragenol
| Code | Size | Price |
|---|
| TAR-TN7020-20mg | 20mg | £148.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Astragenol is an intermediate for the synthesis of astragenel derivatives. Astragenol derivatives are promising anti-inflammatory drugs in prostate cancer research.
CAS:
86541-79-9
Formula:
C60H99O10
Molecular Weight:
980.42
Purity:
0.993
SMILES:
CC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@](C)(O5)CC[C@H]5C(C)(O)C)[C@@H](O)C[C@](C)4[C@]3([H])C[C@H](O)[C@@]12[H]CC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@](C)(O5)CC[C@H]5C(C)(O)C)[C@@H](O)C[C@](C)4[C@]3([H])C[C@H](O)[C@@]12[H]
References
Bilge Debele?-B?t?ner, et al. Cycloartane-type sapogenol derivatives inhibit NF-?B activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis. Steroids. 2018 Jul;135:9-20.